Horizon Surgical Systems

Executive Summary

Horizon Surgical Systems is a private medical device company pioneering the Polaris™ advanced surgical platform for ophthalmic surgery, with a mission to transform cataract care through the integration of robotics, artificial intelligence, and multimodal imaging. The platform is designed to enhance surgical precision, standardize outcomes, and expand access to care by supporting surgeons in performing delicate cataract procedures. Founded in 2018 and headquartered in Fremont, California, the company is in the development stage and has not yet commercialized its investigational system. Horizon targets a large and growing market, as cataract surgery is one of the most common surgical procedures globally, with increasing demand for improved outcomes and efficiency. The Polaris platform represents a significant advancement in ophthalmic surgery by combining robotic assistance, AI-driven analytics, and real-time imaging to potentially reduce variability and complications. If successful, it could set a new standard in cataract care, appealing to both high-volume surgical centers and specialized ophthalmic hospitals. However, as a privately held, pre-commercial entity, Horizon faces typical risks associated with regulatory clearance, clinical validation, and capital requirements. The company's progress will depend on securing funding, achieving key regulatory milestones, and demonstrating clinical efficacy through well-designed studies.

Upcoming Catalysts (preview)

• Q4 2026Initial clinical data from first-in-human studies60% success
• Q2 2026FDA IDE approval or Breakthrough Device Designation50% success
• Q3 2026Series A or B financing round70% success